Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors

Update Il y a 4 ans
Reference: NCT00420485

Woman and Man

Extract

This study will evaluate the Maximum Tolerated Dose and dose limiting toxicity of gimatecan administered orally in patients with advanced solid tumors


Inclusion criteria

  • Solid Tumors


Links